Neil Woodford's Patient Capital Trust is to issue new shares in a tap issuance programme to satisfy 'excess demand' from investors.
Vestra Wealth has hired Russell Harrop, formerly Woodford Investment Management, as head of international equities.
Broker Stifel has recommended investors sell Neil Woodford's Patient Capital trust due to its share price trading at a high premium to NAV.
The fund groups with the best Twitter strategies
The Patient Capital investment trust is to enter the FTSE 250 later this month, two months on from its record fundraising.
Fund managers give their views on the key issues impacting global asset classes and outline how they are positioning portfolios.
Jeremy Beckwith, director of manager research at Morningstar UK, analyses the key lessons that can be learned from the launch of Neil Woodford's new vehicle last month
The Battle Against Cancer investment trust (BACIT) has backed Woodford's Patient Capital trust at launch.